(Q46014277)

18 December 2017

title

ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. (English)

1 reference

18 December 2017

1 reference

1 reference

1 reference

9

Aldons J Lusis

1 reference

18 December 2017

8

Joseph L Witztum

1 reference

18 December 2017

10

Betty P Tsao

1 reference

18 December 2017

author name string

Xuebing Feng

1

1 reference

18 December 2017

Hongyun Li

2

1 reference

18 December 2017

Alexis A Rumbin

3

1 reference

18 December 2017

Xuping Wang

4

1 reference

18 December 2017

Antonio La Cava

5

1 reference

18 December 2017

Katherine Brechtelsbauer

6

1 reference

18 December 2017

Lawrence W Castellani

7

1 reference

18 December 2017

publication date

26 January 2007

1 reference

18 December 2017

Journal of Lipid Research

published in

1 reference

18 December 2017

volume

48

1 reference

18 December 2017

page(s)

794-805

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

Accelerated atherogenesis in autoimmune rheumatic diseases

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Immune responses and bone loss: the estrogen connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Autoimmunity, oxidized LDL and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

SLE, atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

A role for oxidized phospholipids in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Oxidized lipids as mediators of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Osteoporosis in murine systemic lupus erythematosus--a laboratory model

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Dissection of BXSB Lupus Phenotype Using Mice Congenic for Chromosome 1 Demonstrates That Separate Intervals Direct Different Aspects of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Vascular calcification: mechanisms and clinical ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Increased bone formation in mice lacking apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Atherogenic high-fat diet reduces bone mineralization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

The Fas signalling pathway and its role in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Autoantibodies that bind glomeruli: cross-reactivity with bacterial antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600512-JLR200

10.1194/JLR.M600512-JLR200

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

17259598

1 reference

18 December 2017